SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 19, 2000
PROXYMED, INC
(Exact name of registrant as specified in its charter)
FLORIDA 000-22052 65-0202059
------- --------- ----------
(State or other (Commission File No.) (IRS Employer
jurisdiction of Identification No.)
incorporation)
2555 Davie Road
Suite 110
Ft. Lauderdale, Florida 33317
(Address of principal executive offices)
954-473-1001
(Registrant's telephone number, including area code)
Item 5. Other Events.
On May 19, 2000, ProxyMed, Inc. (the "Company") announced that its
Board of Directors has commenced a reorganization aimed at reducing costs and
reallocating resources.
A copy of the press release is attached hereto as Exhibit 99.1.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release issued on May 19, 2000.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PROXYMED, INC.
By: /S/ FRANK M. PUTHOFF
--------------------------------
Name: Frank M. Puthoff
Title: Executive Vice President,
Chief Legal Officer,
and Secretary
Dated: May 19, 2000
3
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Press Release issued on May 19, 2000.